control group:Methotrexate
Sponsors
Shanghai Traditional Chinese Medicine Hospital, China-Japan Friendship Hospital, Beijing Hospital, Peking University People's Hospital, The First Affiliated Hospital of Third Military Medical University
Conditions
Rheumatoid ArthritisRheumatoid arthritisSystemic Sclerosisrheumatoid arthritis
Early Phase 1
Clinical study of Shenshi Qianghuo Dihuang Decoction in the treatment of Rheumatoid arthritis from the perspective of ''7+1''
RecruitingITMCTR2000003850
Start: 2020-10-01Updated: 2023-02-20
Clinical study of Shenshi Qianghuo Dihuang Decoction in the treatment of Rheumatoid arthritis from the perspective of ''7+1''
RecruitingChiCTR2000037675
Start: 2020-10-01Updated: 2020-11-02
Efficacy and safety of JAK inhibitor combined with methotrexate in the treatment of skin involvement in systemic sclerosis
RecruitingChiCTR2300074825
Start: 2023-03-01Updated: 2023-08-21